Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029)
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
Sosiaali- ja terveysministeriö on tehnyt sopimuksen GlaxoSmithKline Oy:n kanssa meningokokki A-, C-, W-135- ja Y-konjugaattirokotteen toimittamisesta Suomen puolustusvoimien ja rajavartiolaitoksen rokotuksiin sekä riskiryhmien rokotuksiin kansallisessa rokotusohjelmassa. Sopimuskausi on 2 vuotta (2026-2027) ja siihen sisältyy kaksi yhden vuoden optiota (1+1) vuosille 2028 ja 2029. Arvioitu määrä sopimuskaudelle optioineen on 112 000 annosta, ja sopimuksen arvo on 2 485 056 euroa. Toimitukset tapahtuvat Helsinki-Uusimaa-alueelle. Sopimus myönnettiin edullisimman hinnan perusteella. Kilpailuun osallistui 2 tarjoajaa.
Result
- Winner
- GlaxoSmithKline Oy
- Number of bids
- 2
- Contract value
- €2,485,056
About the bid
- Contact name
- Hankintayksikkö
- Contact phone
- +358 295246000
- Contact email
- kilpailutus@thl.fi
- Address
- P.O. BOX 33, 00023 Helsinki
The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Meningococcal group A, C, W-135 and Y conjugate vaccine, required for the vaccinations in the Finnish Defence Forces and the Finnish Border Guard and for the risk group vaccinations in the National Vaccination Programme in Finland. The contract period is two years 2026 - 2027. The procurement contains two one-year contract period renewals (1 + 1) to extend the contract for the periods 2028 and 2029. Estimated quantity for the contract period including contract period renewals is 112,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi ServiceMain features of the procedureAn open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
The cheapest price
Evaluation Method
Fixed value (total). The total agreed price is a non-variable sum.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Ministry of Social Affairs and Health
- Title
- Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029)
- Type
- Main code
- Supplemental codes
- Location
- Helsinki-Uusimaa
- Duration
- 24 months